Suppr超能文献

397例连续治疗的脑干海绵状血管畸形的干预时机影响

Impact of Timing of Intervention Among 397 Consecutively Treated Brainstem Cavernous Malformations.

作者信息

Zaidi Hasan A, Mooney Michael A, Levitt Michael R, Dru Alexander B, Abla Adib A, Spetzler Robert F

机构信息

Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.

出版信息

Neurosurgery. 2017 Oct 1;81(4):620-626. doi: 10.1093/neuros/nyw139.

Abstract

BACKGROUND

Surgical resection of brainstem cavernous malformations (BSCMs) is challenging, and patient selection and timing of intervention remain controversial.

OBJECTIVE

To evaluate the impact of surgical timing and predictors of neurological outcome after surgical resection of BSCMs.

METHODS

Consecutive adult patients (≥18 years) with BSCMs undergoing surgical resection between 1985 and 2014 by the senior author (RFS) were retrospectively reviewed. Patient demographics, lesion characteristics, imaging results, surgical approach, and perioperative and long-term neurological morbidity were analyzed.

RESULTS

Data were analyzed for a total of 397 adult patients (160, 40% male). On univariate analysis, a greater proportion of patients treated within 6 weeks of hemorrhage had an improved Glasgow Outcome Scale score (P = .06). On logistic regression analysis, patients treated within 6 weeks of hemorrhage experienced improved clinical outcomes (odds ratio = 1.73; 95% confidence interval = 1.06-2.83; P = .03).

CONCLUSIONS

Although BSCM surgery is associated with significant perioperative morbidity and mortality, favorable long-term hemorrhage rates and symptom resolution can be achieved in a carefully selected group of patients. Overall, patients treated acutely, within 6 weeks, benefited the most from surgical intervention.

摘要

背景

脑干海绵状血管畸形(BSCMs)的手术切除具有挑战性,患者的选择和干预时机仍存在争议。

目的

评估手术时机对BSCMs手术切除后神经功能结局的影响以及神经功能结局的预测因素。

方法

对1985年至2014年间由资深作者(RFS)进行手术切除的连续性成年(≥18岁)BSCMs患者进行回顾性研究。分析患者的人口统计学资料、病变特征、影像学结果、手术方式以及围手术期和长期神经功能并发症。

结果

共分析了397例成年患者的数据(160例,40%为男性)。单因素分析显示,出血后6周内接受治疗的患者中,格拉斯哥预后量表评分改善的比例更高(P = 0.06)。逻辑回归分析显示,出血后6周内接受治疗的患者临床结局改善(优势比 = 1.73;95%置信区间 = 1.06 - 2.83;P = 0.03)。

结论

尽管BSCM手术与显著的围手术期发病率和死亡率相关,但在精心挑选的患者群体中可实现良好的长期出血率和症状缓解。总体而言,在6周内接受急症治疗的患者从手术干预中获益最大。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验